{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:06:27Z","timestamp":1793844387637,"version":"4.6.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gaceta Sanitaria"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.gaceta.2019.08.007","type":"journal-article","created":{"date-parts":[[2019,11,24]],"date-time":"2019-11-24T16:01:11Z","timestamp":1574611271000},"page":"318-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluaci\u00f3n econ\u00f3mica de la inclusi\u00f3n en el calendario vacunal de 4CMenB (Bexsero\u00ae) en Espa\u00f1a"],"prefix":"10.1016","volume":"34","author":[{"given":"Rafael","family":"Ruiz-Montero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Guzm\u00e1n Herrador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Esp\u00edn Balbino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gaceta.2019.08.007_bib0150","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"24","author":"Harrison","year":"2009","journal-title":"Vaccine."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0155","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0160","unstructured":"Protocolos de la Red Nacional de Vigilancia Epidemiol\u00f3gica. Centro Nacional de Epidemiolog\u00eda. Instituto de Salud Carlos III. Madrid; 2013. 680 p. Disponible en: http:\/\/www.isciii.es\/ISCIII\/es\/contenidos\/fd-servicios-cientifico-tecnicos\/fd-vigilancias-alertas\/fd-procedimientos\/PROTOCOLOS_RENAVE-ciber.pdf."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0165","unstructured":"European Centre for Disease Prevention and Control. Annual epidemiological report for 2016. Invasive meningococcal disease. Stockholm: ECDC; 2018. 11 p. Disponible en: https:\/\/ecdc.europa.eu\/en\/publications-data\/invasive-meningococcal-disease-annual-epidemiological-report-2016."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0170","unstructured":"Red Nacional de Vigilancia Epidemiol\u00f3gica. Enfermedad meningoc\u00f3cica. Vigilancia de la temporada 2017-2018. Resultados de la Red Nacional de Vigilancia Epidemiol\u00f3gica. Instituto de Salud Carlos III. Madrid; 2019. 12 p. Disponible en: http:\/\/www.isciii.es\/ISCIII\/es\/contenidos\/fd-servicios-cientifico-tecnicos\/fd-vigilancias-alertas\/fd-enfermedades\/fd-enfermedades-prevenibles-vacunacion\/pdf_2019\/RENAVE_EMI-2017-18.pdf."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0175","unstructured":"Bexsero\u00ae. Ficha t\u00e9cnica del medicamento. CHMP. Bexsero, common name - meningococcal group B vaccine (rDNA, component, adsorbed). European Medicines Agency; 2019. 37 p. Disponible en: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/bexsero-epar-product-information_en.pdf."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0180","doi-asserted-by":"crossref","first-page":"e0150721","DOI":"10.1371\/journal.pone.0150721","article-title":"Predicted strain coverage of a new meningococcal multicomponent vaccine (4CMenB) in Spain: analysis of the differences with other European countries","volume":"11","author":"Abad","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0185","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","article-title":"Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study","volume":"388","author":"Parikh","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0190","unstructured":"Grupo de Trabajo Criterios 2011, de la Ponencia de Programa y Registro de Vacunaciones. Criterios de evaluaci\u00f3n para fundamentar modificaciones en el Programa de Vacunaci\u00f3n en Espa\u00f1a. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Pol\u00edtica Social e Igualdad. Madrid; 2011. 92 p. Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/Criterios_ProgramaVacunas.pdf."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0195","unstructured":"Grupo de trabajo de uso de 4CMenB en situaciones especiales. Recomendaciones de utilizaci\u00f3n de la vacuna frente a la enfermedad meningoc\u00f3cica por serogrupo B. Ministerio de Sanidad, Servicios Sociales e Igualdad. Madrid; 2015. 34 p. Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/MenB_situacEspeciales.pdf."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0200","first-page":"15","author":"Limia S\u00e1nchez","year":"2017","journal-title":"Utilizaci\u00f3n de la vacuna Bexsero en Espa\u00f1a en 2016 Ministerio de Sanidad, Servicios Sociales e Igualdad. Madrid"},{"key":"10.1016\/j.gaceta.2019.08.007_bib0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.anpedi.2014.09.004","article-title":"Vacunaci\u00f3n frente al meningococo B. Posicionamiento del Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda","volume":"82","author":"Moreno-P\u00e9rez","year":"2015","journal-title":"An Pediatr."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0210","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.gaceta.2009.07.011","article-title":"Propuesta de gu\u00eda para la evaluaci\u00f3n econ\u00f3mica aplicada a las tecnolog\u00edas sanitarias","volume":"24","author":"L\u00f3pez Bastida","year":"2010","journal-title":"Gac Sanit."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0215","unstructured":"Espa\u00f1a en cifras 2017. Instituto Nacional de Estad\u00edstica. (Consultado el 9\/3\/2019.) Disponible en: http:\/\/www.ine.es\/prodyser\/espa_cifras\/2017\/index.html#10."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0220","unstructured":"Esperanza de vida al nacimiento seg\u00fan sexo. Instituto Nacional de Estad\u00edstica. (Consultado el 9\/3\/2019.) Disponible en: http:\/\/www.ine.es\/jaxiT3\/Datos.htm?t=1414."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0225","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/21645515.2016.1160177","article-title":"Vaccinating Italian infants with a new multicomponent vaccine (Bexsero\u00ae) against meningococcal B disease: a cost-effectiveness analysis","volume":"12","author":"Gasparini","year":"2016","journal-title":"Hum Vaccin Immunother."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0230","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1473-3099(18)30048-3","article-title":"Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis","volume":"18","author":"Flacco","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0235","unstructured":"Resultados de la vigilancia epidemiol\u00f3gica de las enfermedades transmisibles. Informe anual 2014. Centro Nacional de Epidemiolog\u00eda. CIBER de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP). Instituto de Salud Carlos III. Madrid; 2016. 122 p. Disponible en: http:\/\/gesdoc.isciii.es\/gesdoccontroller?action=download&id=14\/10\/2016-3a996e69f2."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0240","unstructured":"Vallejo-Torres L, Garc\u00eda-Lorenzo B, Castilla I, et al. Valor monetario de un a\u00f1o de vida ajustado por calidad: estimaci\u00f3n emp\u00edrica del coste de oportunidad en el Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad. Servicio de Evaluaci\u00f3n del Servicio Canario de la Salud; 2015. Informes de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias. Disponible en: https:\/\/www3.gobiernodecanarias.org\/sanidad\/scs\/contenidoGenerico.jsp?idDocument=e690e0c1-cbed-11e5-a9c5-a398589805dc&idCarpeta=ce590e62-7af0-11e4-a62a-758e414b4260."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0272989X8500500205","article-title":"Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach","volume":"5","author":"Doubilet","year":"1985","journal-title":"Med Decis Making."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0250","unstructured":"Hospital Universitario Reina Sof\u00eda. Vacuna meningoc\u00f3cica del grupo B. Informe de la Comisi\u00f3n de Farmacia. Hospital Universitario Reina Sof\u00eda. C\u00f3rdoba; 2014. 5 p. Disponible en: https:\/\/www.juntadeandalucia.es\/servicioandaluzdesalud\/hrs3\/fileadmin\/user_upload\/area_atencion_alprofesional\/comision_farmacia\/informes\/bexsero.pdf."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0255","first-page":"140","article-title":"Meningococcal B vaccine and the vision of a meningitis free world","volume":"56","author":"Bianchi","year":"2015","journal-title":"J Prev Med Hyg."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0260","unstructured":"Grupo de Trabajo MenB. Vacuna frente a la enfermedad meningoc\u00f3cica invasora por serogrupo B y su posible utilizaci\u00f3n en salud p\u00fablica. Ponencia de Programas y Registro de Vacunaciones. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad. Madrid; 2013. 76 p. Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/MenB.pdf."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.medcli.2017.07.018","article-title":"Pros y contras de la vacunaci\u00f3n frente a la enfermedad por meningococo B","volume":"150","author":"Rodr\u00edguez","year":"2018","journal-title":"Med Clin."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0270","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1016\/j.vaccine.2016.04.004","article-title":"Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero\u00ae to reduce meningococcal group B disease in Germany","volume":"34","author":"Christensen","year":"2016","journal-title":"Vaccine."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0275","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.vaccine.2016.03.020","article-title":"Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France","author":"Lecocq","year":"2016","journal-title":"Vaccine."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0280","doi-asserted-by":"crossref","first-page":"g5725","DOI":"10.1136\/bmj.g5725","article-title":"Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study","volume":"349","author":"Christensen","year":"2014","journal-title":"BMJ."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0285","unstructured":"Informe del Grupo de Vacunas de la Sociedad Espa\u00f1ola de Salud P\u00fablica y Administraci\u00f3n Sanitaria (SESPAS) sobre la vacunaci\u00f3n frente a la enfermedad meningoc\u00f3cica por serogrupo B. Sociedad Espa\u00f1ola de Salud P\u00fablica y Administraci\u00f3n Sanitaria (SESPAS); 2015. 2 p. Disponible en: https:\/\/www.unav.edu\/documents\/16089811\/16216616\/menB_vac-meningitis-B-informe-SESPAS+%281%29.pdf."},{"key":"10.1016\/j.gaceta.2019.08.007_bib0290","unstructured":"Posicionamiento SESPAS sobre el calendario vacunal recomendado en Espa\u00f1a. Posicionamiento SESPAS 04\/2019. Sociedad Espa\u00f1ola de Salud P\u00fablica y Administraci\u00f3n Sanitaria (SESPAS); 2019. 5 p. (consultado el 20\/6\/2019). Disponible en: https:\/\/sespas.es\/2019\/05\/03\/posicionamiento-de-sespas-sobre-el-calendario-vacunal-recomendado-en-espana\/."}],"container-title":["Gaceta Sanitaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213911119302171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213911119302171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:19:28Z","timestamp":1759324768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213911119302171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0213911119302171"],"URL":"https:\/\/doi.org\/10.1016\/j.gaceta.2019.08.007","relation":{},"ISSN":["0213-9111"],"issn-type":[{"value":"0213-9111","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluaci\u00f3n econ\u00f3mica de la inclusi\u00f3n en el calendario vacunal de 4CMenB (Bexsero\u00ae) en Espa\u00f1a","name":"articletitle","label":"Article Title"},{"value":"Gaceta Sanitaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gaceta.2019.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 SESPAS. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}